Impact of calcification on the long-term outcomes of sirolimus-eluting stent implantation-subanalysis of the cypher post-marketing surveillance registry-

Circulation Journal

Volumn 76, Issue 1, 2012, Pages 57-64

  Fujimoto, Hajime ^a   Nakamura, Masato ^b   Yokoi, Hiroyoshi ^c  

^a TORANOMON HOSPITAL   (Japan)

^b TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^c KOKURA MEMORIAL HOSPITAL   (Japan)

Author keywords

Calcification; Dialysis; Drug eluting stent; Restenosis; Revascularization

Indexed keywords

RAPAMYCIN;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DISEASE SEVERITY; DRUG ELUTING STENT; FEMALE; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; JAPAN; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; POSTMARKETING SURVEILLANCE; REGISTER; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CALCINOSIS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; DRUG-ELUTING STENTS; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PRODUCT SURVEILLANCE, POSTMARKETING; REGISTRIES; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SIROLIMUS; TREATMENT OUTCOME;

EID: 84255172480     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0738     Document Type: Article

References (33)

1. Alfonso F, Macaya C, Iniguez A, Fernandez Ortiz A, Zarco P. Coronary angioplasty of calcified lesions. Rev Esp Cardiol 1990; 43: 231-238.
2. Moussa I, Di Mario C, Moses J, Reimers B, Di Francesco L, Martini G, et al. Coronary stenting after rotational atherectomy in calcified and complex lesions: Angiographic and clinical follow-up results. Circulation 1997; 96: 128-136.
3. Warth D, Leon M, O'Neill W, Zacca N, Polissar N, Buchbinder M. Rotational atherectomy multicenter registry: Acute results, complications and 6-month angiographic follow-up in 709 patients. J Am Coll Cardiol 1994; 24: 641-648.
4. Henson K, Popma J, Leon M, Kent K, Satler L, Mintz G, et al. Comparison of results of rotational coronary atherectomy in three age groups (<70, 70-79, and >80 years). Am J Cardiol 1993; 71: 862-864.
5. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
6. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
7. Schofer J, Schlüter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003; 362: 1093-1099.
8. Schampaert E, Cohen EA, Schlüter M, Reeves F, Traboulsi M, Title LM, et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004; 43: 1110-1115.
9. Fujii K, Mintz G, Kobayashi Y, Carlier S, Takebayashi H, Yasuda T, et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 2004; 109: 1085-1088.
10. Hong MK, Mintz GS, Lee CW, Park DW, Choi BR, Park KH, et al. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J 2006; 27: 1305-1310.
11. Morice MC, Colombo A, Meier B, Serruys P, Tamburino C, Guagliumi G, et al. Sirolimus-vs. paclitaxel-eluting stents in de novo coronary artery lesions: The REALITY trial: A randomized controlled trial. JAMA 2006; 295: 895-904.
12. Kandzari DE, Leon MB, Popma JJ, Fitzgerald PJ, O'Shaughnessy C, Ball MW, et al. Comparison of zotarolimus-eluting and sirolimuseluting stents in patients with native coronary artery disease: A randomized controlled trial. J Am Coll Cardiol 2006; 48: 2440-2447.
13. Kedhi E, Joesoef KS, McFadden E, Wassing J, van Mieghem C, Goedhart D, et al. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): A randomized trial. Lancet 2010; 375: 201-209.
14. Rasmussen K, Maeng M, Kaltoft A, Thayssen P, Kelbaek H, Tilsted HH, et al. Efficacy and safety of zotarolimus-eluting and sirolimuseluting coronary stents in routine clinical care (SORT OUT III): A randomised controlled superiority trial. Lancet 2010; 375: 1090-1099.
15. Kawaguchi R, Tsurugaya H, Hoshizaki H, Toyama T, Oshima S, Taniguchi K. Impact of lesion calcification on clinical and angiographic outcome after sirolimus-eluting stent implantation in realworld patients. Cardiovasc Revasc Med 2008; 9: 2-8.
16. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al; Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344-2351.
17. Iijima K, Akishita M, Ouchi Y. Coronary artery calcification and cerebral small vessel disease. Association of systemic atherosclerosis. Circ J 2011; 75: 272-273.
18. Kim BJ, Lee SH, Kim CK, Ryu WS, Kwon HM, Choi SY, et al. Advanced coronary artery calcification and cerebral small vessel diseases in the healthy elderly. Circ J 2011; 75: 451-456.
19. Lee HY, Oh BH. Aging and arterial stiffness. Circ J 2010; 74: 2257-2262.
20. Okada T, Hayashi Y, Toyofuku M, Imazu M, Otsuka M, Sakuma T, et al. One-year clinical outcomes of dialysis patients after implantation with sirolimus-eluting coronary stents. Circ J 2008; 72: 1430-1435.
21. Aoyama T, Ishii H, Toriyama T, Takahashi H, Kasuga H, Murakami R, et al. Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J 2008; 72: 56-60.
22. Ishio N, Kobayashi Y, Takebayashi H, Iijima Y, Kanda J, Nakayama T, et al. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J 2007; 71: 1525-1529.
23. Daemen J, Lemos P, Aoki J, Arampatzis C, Hoye A, McFadden E, et al. Treatment of coronary artery disease in dialysis patients with sirolimus-eluting stents: 1-year clinical follow-up of a consecutive series of cases. J Invasive Cardiol 2004; 16: 685-687.
24. Nakazawa G, Tanabe K, Aoki J, Yamamoto H, Higashikuni Y, Onuma Y, et al. Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents. Catheter Cardiovasc Interv 2007; 69: 808-814.
25. Drueke TB. Arterial intima and media calcification: Distinct entities with different pathogenesis or all the same? Clin J Am Soc Nephrol 2008; 3: 1583-1584.
26. McCullough PA, Agrawal V, Danielewicz E, Abela GS. Accelerated atherosclerotic calcification and Monckebergs's sclerosis: A continuum of advanced vascular pathology in chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1585-1598.
27. Nakamura S, Ishibashi H, Niizuma S, Yoshihara F, Horio T, Kawano Y. Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol 2009; 4: 1892-1900.
28. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 2000; 102: 2636-2642.
29. Stenvinkel P, Ketteler M, Johnson RJ. IL-10, IL-6, and TNF-alpha: Central factors in the altered cytokine network of uremia: The good, the bad, and the ugly. Kidney Int 2005; 67: 1216-1233.
30. Watson KE, Parhami F, Shin V, Demer LL. Fibronectin and collagen I matrixes promote calcification of vascular cells in vitro, whereas collagen IV matrix is inhibitory. Arterioscler Thromb Vasc Biol 1998; 18: 1964-1971.
31. Otsuka M, Toyofuku M, Watanabe N, Motoda C, Kawase T, Takeda R, et al. Clinical usefulness of drug-eluting stents in the treatment of dialysis patients with coronary artery disease. EuroIntervention 2011; 6: 754-759.
32. Yazaki Y, Iijima R, Nakamura M, Sugi K. Relationship between renal function stage and clinical outcomes after paclitaxel-eluting stent implantation. J Cardiol 2011; 57: 61-68.
33. Takeuchi I, Moriguchi M, Imaki R, Fukaya H, Shinagawa H, Shimohama T, et al. Hemodialysis is an independent predictor of coronary in-stent restenosis after paclitaxel eluting stent implantation. Intern Med 2010; 49: 2379-2384.